Mumbai Experience Center reflects Agilent’s continued commitment to India Viveka Roychowdhury Apr 2, 2026 Bharat Bhardwaj, Vice President, Asia Pacific, Agilent Technologies spoke to Viveka Roychowdhury on why Agilent has been…
Industrial and infrastructure sectors are undergoing rapid modernisation EP News Bureau Mar 12, 2026 How critical is infrastructure automation in pharma facilities? Infrastructure is integral to maintaining controlled…
Companies need to look at anti-counterfeiting solutions from the perspective of protecting revenue,… Viveka Roychowdhury Mar 12, 2026 Can you briefly explain ASPA’s evolution and how the anti‑counterfeiting ecosystem has changed? ASPA as an organisation started…
What truly differentiates Transchem is our technical-first approach Lakshmipriya Nair Mar 12, 2026 What are Transchem's core focus areas today, and which segments are driving your growth? Transchem’s core focus today is on…
Targeted incentives for innovation-driven research would further strengthen India’s biotech… Lakshmipriya Nair Mar 10, 2026 What unmet need are you fundamentally solving? Vyome is focused on areas of significant unmet medical need within…
In 2026, India serves as the reliable ‘technical engine’ for global research Swati Rana Mar 9, 2026 How would you describe the current and evolving clinical research landscape in India, and what key shifts are shaping its future?…
Our approach is to combine localised production with global quality standards Viveka Roychowdhury Mar 5, 2026 What do you see as India’s role in the evolving global life sciences and biopharma value chain over the next decade? India is…
India has the infrastructure to lead the global gene therapy market Mar 2, 2026 AI is often described as a game changer in drug discovery and manufacturing. Where do you see it making the biggest difference…
BMS is committed to pioneering AI-driven innovation in pharma commercialisation Swati Rana Feb 12, 2026 AI is reshaping pharma commercialisation, transforming how companies engage healthcare professionals and deliver scientific…
Automation, digitalisation, and integrated workflows are redefining India’s life sciences landscape Swati Rana Feb 11, 2026 Nandakumar Kalathil, Country General Manager – India, Agilent Technologies, shares insights into Agilent’s performance, strategic…
Quick-commerce players are rapidly gaining share in acute, event-based medicines Lakshmipriya Nair Feb 6, 2026 Quick commerce is reshaping pharma distribution. But the real transformation is happening deeper in the supply chain. Uday Kadam,…
Rx-to-OTC is not a channel shift—it’s a complete business model shift Swati Rana Feb 2, 2026 By 2030, what will truly differentiate winning OTC players in India from the rest? By 2030, the biggest differentiator for…
Good pharma-focused developers are now co-designing with GMP/WHO/USFDA consultants from day zero EP News Bureau Jan 31, 2026 How have pharma companies changed the way they plan and choose real estate after the pandemic? What matters most to them now,…
Local focus to strengthen Indian pharmaceutical manufacturers EP News Bureau Jan 30, 2026 Why is localising format part production an important step for Indian pharmaceutical companies and Romaco? Sanjeev Nimkar: It…
India at a jumping-off point in terms of commitment to global clinical studies Viveka Roychowdhury Jan 21, 2026 If you were to pick one or two trends in clinical trials and research in India in 2026, what would you be looking at? What are the…
Speed and flexibility play a critical role in how we compete with larger global players EP News Bureau Jan 19, 2026 As a young leader stepping into a global business, how do you envision the next phase of growth for Shriji Polymers? As a young…
Our goal is to help companies reduce cost per cubic meter of wastewater treatment Viveka Roychowdhury Jan 14, 2026 The pharma industry is considered one of the most polluting industries, not just in India, but across the world. Antibiotics have…
We train professionals to see quality not as a checklist but as a mindset Kalyani Sharma Jan 12, 2026 How does IGMPI’s training ecosystem directly address the root causes of patient safety lapses such as weak documentation,…
Quality Trailblazer emphasises that leadership commitment is non-negotiable Swati Rana Jan 9, 2026 What motivated you to write Quality Trailblazer, and how does it address the most pressing quality challenges faced by the Indian…
Supriya Lifescience ramps up capacity and global readiness for next phase of growth Swati Rana Jan 8, 2026 Supriya Lifescience has built a strong global presence in Active Pharmaceutical Ingredients. What has guided this journey? Our…